Φιλτράρισμα ανά Last updated date SelectΜετάΠρινFrom - To Date Ημερομηνία λήξης This week This month Last week Last month Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationMedicine shortagesResearch and developmentBiosimilarsSMEAntimicrobial resistanceCorporateGovernanceBrexitQuality of medicinesGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationScientific adviceMedical devicesMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate usePRIMECareersMedication errorParallel distributionProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety information Patient safety Leave this field blank Filter Αποτελέσματα (3839) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Leave this field blank Oncoscience AG withdraws its application for Theraloc (nimotuzumab) 4 Δεκέμβριος 2008Press releaseHuman Meeting highlights from the Paediatric Committee:12 - 14 November 2008 26 Νοέμβριος 2008Press releaseHumanPaediatrics Meeting highlights from the Committee for Medicinal Products for Human Use,17-20 November 2008 21 Νοέμβριος 2008Press releaseHuman European Medicines Agency recommends the suspension of the marketing authorisation of Ionsys (fentanyl hydrochloride) 20 Νοέμβριος 2008Press releaseHumanMedicines Pfizer withdraws its application to change the marketing authorisation for Viagra 50 mg (sildenafil) from prescription-only to non-prescription 20 Νοέμβριος 2008Press release Successful Rijeka conference strengthens EU-Croatian cooperation on medicines regulation 18 Νοέμβριος 2008Press release Sanofi-Aventis Pharma S.A. withdraws its application for an extension of indication for Taxotere and Docetaxel Winthrop (docetaxel) 17 Νοέμβριος 2008Press release Novagali Pharma S.A. withdraws its marketing authorisation application for Vekacia (ciclosporin) 17 Νοέμβριος 2008Press release Committee for medicinal products for veterinary use: Meeting of 11-13 November 2008 14 Νοέμβριος 2008Press releaseVeterinary Astellas withdraws its marketing authorisation application for Vibativ (telavancin) 24 Οκτώβριος 2008Press release 1 … 308 309 310 311 312 Page 312 of 384 313 314 315 316 … 384
Oncoscience AG withdraws its application for Theraloc (nimotuzumab) 4 Δεκέμβριος 2008Press releaseHuman
Meeting highlights from the Paediatric Committee:12 - 14 November 2008 26 Νοέμβριος 2008Press releaseHumanPaediatrics
Meeting highlights from the Committee for Medicinal Products for Human Use,17-20 November 2008 21 Νοέμβριος 2008Press releaseHuman
European Medicines Agency recommends the suspension of the marketing authorisation of Ionsys (fentanyl hydrochloride) 20 Νοέμβριος 2008Press releaseHumanMedicines
Pfizer withdraws its application to change the marketing authorisation for Viagra 50 mg (sildenafil) from prescription-only to non-prescription 20 Νοέμβριος 2008Press release
Successful Rijeka conference strengthens EU-Croatian cooperation on medicines regulation 18 Νοέμβριος 2008Press release
Sanofi-Aventis Pharma S.A. withdraws its application for an extension of indication for Taxotere and Docetaxel Winthrop (docetaxel) 17 Νοέμβριος 2008Press release
Novagali Pharma S.A. withdraws its marketing authorisation application for Vekacia (ciclosporin) 17 Νοέμβριος 2008Press release
Committee for medicinal products for veterinary use: Meeting of 11-13 November 2008 14 Νοέμβριος 2008Press releaseVeterinary
Astellas withdraws its marketing authorisation application for Vibativ (telavancin) 24 Οκτώβριος 2008Press release